Literature DB >> 25456636

Radiographic parameters associated with pain following total hip and surface arthroplasty.

Denis Nam1, Timothy J Sauber2, Toby Barrack1, Staci R Johnson1, Peter J Brooks3, Ryan M Nunley1.   

Abstract

Pain following total hip arthroplasty (THA) and surface arthroplasty (SRA) remains a significant source of patient dissatisfaction. Two hundred twenty-four SRA and 196 THA patients completed a pain drawing questionnaire and postoperative radiographic measurements of component positioning were performed. In the SRA cohort, 11 of 21 patients (52%) with acetabular uncoverage of ≥5 mm versus 43 of 147 (29%) with acetabular uncoverage of ≤4.9 mm reported groin pain (P=.03). In the THA cohort, an increased distal-third canal fill ratio and a lower canal calcar ratio trended towards a higher incidence of thigh pain (P=.10 and .06), while a decreased mid-third canal fill ratio was associated with increased severity of thigh pain (P=.04). This study identifies associations between radiographic findings and pain following THA and SRA.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  acetabulum; femoral stem; hip arthroplasty; pain; radiographs

Mesh:

Year:  2014        PMID: 25456636     DOI: 10.1016/j.arth.2014.10.005

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  2 in total

1.  Influence of femoral morphology and canal fill ratio on early radiological and clinical outcomes of uncemented total hip arthroplasty using a fully coated stem.

Authors:  Adrien D'Ambrosio; Lisa Peduzzi; Olivier Roche; Hugo Bothorel; Mo Saffarini; François Bonnomet
Journal:  Bone Joint Res       Date:  2020-05-16       Impact factor: 5.853

2.  An evaluation of proximal femur bone density in young, active patients undergoing total hip arthroplasty at one year postoperatively.

Authors:  Denis Nam; Rondek Salih; Robert L Barrack; Ryan M Nunley
Journal:  Hip Int       Date:  2018-05-04       Impact factor: 2.135

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.